請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/59780
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳端容 | |
dc.contributor.author | Chloe Lo | en |
dc.contributor.author | 羅可倩 | zh_TW |
dc.date.accessioned | 2021-06-16T09:37:36Z | - |
dc.date.available | 2017-03-01 | |
dc.date.copyright | 2017-03-01 | |
dc.date.issued | 2017 | |
dc.date.submitted | 2017-02-10 | |
dc.identifier.citation | 內政部(2016)。人口統計資料。取自:www.moi.gov.tw/
方茂守(2005)。都市原住民婦女更年期症狀與更年期態度之探討(未出版碩士論文)。高雄醫學大學護理學系研究所學位論文。 白香菊(2003)。更年期婦女對更年期知識,不確定感及親子關係之研究(未出版碩士論文)。中山醫學大學,台中市。 自由時報。更年期不適 婦砸百萬吃「偏方」。檢自:http://news.ltn.com.tw/news/life/paper/173231。 自由時報。醫藥信箱�更年期Greene量表 台灣目前只有女性版。檢自:http://news.ltn.com.tw/news/life/paper/180474。 宋敏如(2006)。瑜珈運動對更年期婦女疲憊、健康體能與更年期症狀困擾成效之探討(未出版之碩士論文)。國立台北護理健康大學,台北市。 李佩珊、李絳桃、黃久美、李奇龍(2006)。更年期婦女之更年期態度、更年期症狀與憂鬱情緒之相關性研究。實證護理,2(2),156 -165。 李建明、黃素妃、陳政友、羅應嘉、林昭光、游麗惠、潘佩君(2007)。健走運動對改善更年期婦女骨密度與健康體適能之研究。北市醫學雜誌4(3),235-244。 張文典、蔡建宗、林鋐宇、劉榮啟、黎秉東(2012)。更年期憂鬱症狀與心律變異度及相關因子之探討。身心障礙研究,10(3),196-210。 莊淑屏(2006)。社會依賴性格與自主性格,人際事件與自主事件對更年期婦女的憂鬱及心理症狀的影響(未出版之碩士論文)。成功大學,台南市。 許嘉玲(2014)。更年期婦女之運動行為對更年期症狀及生活品質的探討(未出版碩士論文)。國立高雄大學,高雄市。 黃惠美(2007)。某醫學中心婦產科門診 45-60 歲婦女更年期症狀與生活品質之關係(未出版碩士論文)。 黃筱媛(2008)。停經女性醫療利用與生活品質分析(未出版碩士論文)。台北醫學大學,台北市。 衛生福利部國民健康署(2009)。民國98年國民健康訪問調查成果報告。 鄧振華(2006)。女性更年期憂鬱症中醫藥研究進展探討。中醫內科醫學雜誌,4(2),14-28。 APA. (2000). Diagnostic and statistical manual of mental disorders. DSM IV-4th edition. APA, 1994. Avis, N. E., Stellato, R., Crawford, S., Bromberger, J., Ganz, P., Cain, V., & Kagawa-Singer, M. (2001). Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Social science & medicine, 52(3), 345-356. Baczyk, G., Chuchracki, M., & Opala, T. (2013). Effect of selected socio-demographic, clinical and biochemical factors on self-reported quality of life among post-menopausal women with osteoporosis. Annals of Agricultural and Environmental Medicine, 20(4). Bindhu, S. A., Bindhu, S. A., & Krishnagiri, V. (2013). Climacteric symptoms among women in a rural area in Kerala. Journal of Evolution of Medical and Dental Sciences, 1(2), 3207-3214. Bromberger, J. T., & di Scalea, T. L. (2009). Longitudinal associations between depression and functioning in midlife women. Maturitas, 64(3), 145-159. Bromberger, J. T., & Kravitz, H. M. (2011). Mood and Menopause: Findings from the Study of Women’s Health Across the Nation (SWAN) over ten years. Obstetrics and gynecology clinics of North America, 38(3), 609. Bromberger, J. T., Kravitz, H. M., Chang, Y.-F., Cyranowski, J. M., Brown, C., & Matthews, K. A. (2011). Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN). Psychological medicine, 41(09), 1879-1888. Bromberger, J. T., Matthews, K. A., Schott, L. L., Brockwell, S., Avis, N. E., Kravitz, H. M., Randolph, J. F. (2007). Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN). Journal of affective disorders, 103(1), 267-272. Bromet, E., Andrade, L. H., Hwang, I., Sampson, N. A., Alonso, J., De Girolamo, G., . . . Iwata, N. (2011). Cross-national epidemiology of DSM-IV major depressive episode. BMC medicine, 9(1), 1. Burt, V. K., Wohlreich, M. M., Mallinckrodt, C. H., Detke, M. J., Watkin, J. G., & Stewart, D. E. (2005). Duloxetine for the treatment of major depressive disorder in women ages 40 to 55 years. Psychosomatics, 46(4), 345-354. Campbell, K. E., Szoeke, C. E., & Dennerstein, L. (2015). The course of depressive symptoms during the postmenopause: a review. Women's Midlife Health, 1(1), 1. Canney, P., & Hatton, M. (1994). The prevalence of menopausal symptoms in patients treated for breast cancer. Clinical oncology, 6(5), 297-299. Chattha, R., Kulkarni, R., Nagarathna, R., & Nagendra, H. (2008). Factor analysis of Greene's Climacteric Scale for Indian women. Maturitas, 59(1), 22-27. Chedraui, P., Aguirre, W., Hidalgo, L., & Fayad, L. (2007). Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale. Maturitas, 57(3), 271-278. Chen, H.-Y., Lin, Y.-H., Wu, J.-C., Chen, Y.-C., Yang, S.-H., Chen, J.-L., & Chen, T.-J. (2011). Prescription patterns of Chinese herbal products for menopausal syndrome: analysis of a nationwide prescription database. Journal of Ethnopharmacology, 137(3), 1261-1266. Chen, L.-C., Wang, B.-R., Chen, I.-C., & Shao, C.-H. (2010). Use of Chinese herbal medicine among menopausal women in Taiwan. International Journal of Gynecology & Obstetrics, 109(1), 63-66. Chen, P. L., Chao, H. T., Chou, K. R., Huang, H. M., Cheng, S. Y., Utian, W. H., & Liao, Y. M. (2012). The Chinese Utian Quality of Life Scale for women around menopause: translation and psychometric testing. Menopause: The Journal of The North American Menopause Society, 19(4), 438-447. Cohen, L. S., Soares, C. N., Vitonis, A. F., Otto, M. W., & Harlow, B. L. (2006). Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Archives of general psychiatry, 63(4), 385-390. Davis, S. R., Santoro, N., Lambrinoudaki, I., Lumsden, M., Mishra, G. D., Pal, L., & Simoncini, T. (2015). Authors' reply: Communicating evidence-based practice in menopause. Nature Reviews Disease Primers, 1, 15004. Deecher, D., Andree, T. H., Sloan, D., & Schechter, L. E. (2008). From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology, 33(1), 3-17. Elavsky, S., & McAuley, E. (2007). Physical activity and mental health outcomes during menopause: a randomized controlled trial. Annals of Behavioral Medicine, 33(2), 132-142. Erez, H. B., Weller, A., Vaisman, N., & Kreitler, S. (2012). The relationship of depression, anxiety and stress with low bone mineral density in post-menopausal women. Archives of osteoporosis, 7(1-2), 247-255. Freeman, E. W., Sammel, M. D., Boorman, D. W., & Zhang, R. (2014). Longitudinal pattern of depressive symptoms around natural menopause. JAMA psychiatry, 71(1), 36-43. Freeman, E. W., Sammel, M. D., Lin, H., Gracia, C. R., Pien, G. W., Nelson, D. B., & Sheng, L. (2007). Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstetrics & Gynecology, 110(2, Part 1), 230-240. Freeman, E. W., Sammel, M. D., Lin, H., & Nelson, D. B. (2006). Associations of hormones and menopausal status with depressed mood in women with no history of depression. Archives of general psychiatry, 63(4), 375-382. Freeman, E. W., Sammel, M. D., Liu, L., Gracia, C. R., Nelson, D. B., & Hollander, L. (2004). Hormones and menopausal status as predictors of depression in womenin transition to menopause. Archives of general psychiatry, 61(1), 62-70. Freeman, M. P., Hibbeln, J. R., Silver, M., Hirschberg, A. M., Wang, B., Yule, A. M., . . . Joffe, H. (2011). Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial. Menopause (New York, NY), 18(3), 279. Frey, B. N., Haber, E., Mendes, G. C., Steiner, M., & Soares, C. N. (2013). Effects of quetiapine extended release on sleep and quality of life in midlife women with major depressive disorder. Archives of women's mental health, 16(1), 83-85. Gabarrón, H. E., Vidal, R. J., Haro, A. J., Boix, S. I., Jover, B. A., & Arenas, P. M. (2002). [Prevalence and detection of depressive disorders in primary care]. Atencion primaria/Sociedad Espanola de Medicina de Familia y Comunitaria, 29(6), 329-336; discussion 336-327. Galloway, K. (1975). The middle years The Change of Life. AJN The American Journal of Nursing, 75(6), 1006-1011. Gordon, J. L., Girdler, S. S., Meltzer-Brody, S. E., Stika, C. S., Thurston, R. C., Clark, C. T., . . . Wisner, K. L. (2015). Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. American Journal of Psychiatry, 172(3), 227-236. Greene, J. (1976). A factor analytic study of climacteric symptoms. Journal of Psychosomatic Research, 20(5), 425-430. Greene, J. (1991). Guide to the Greene climacteric scale. Glasgow: University of Glasgow. Greene, J. G. (1984). The social and psychological origins of the climacteric syndrome: Gower Publishing Company. Greene, J. G. (1998). Constructing a standard climacteric scale. Maturitas, 29(1), 25-31. Harlow, B. L., MacLehose, R. F., Smolenski, D. J., Soares, C. N., Otto, M. W., Joffe, H., & Cohen, L. S. (2013). Disparate rates of new-onset depression during the menopausal transition in 2 community-based populations: real, or really wrong? American journal of epidemiology, kws365. Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., . . . De Villiers, T. J. (2012). Executive summary of the Stages of Reproductive Aging Workshop+ 10: addressing the unfinished agenda of staging reproductive aging. Climacteric, 15(2), 105-114. Hauser, G., Huber, I., Keller, P., Lauritzen, C., & Schneider, H. (1993). [Evaluation of climacteric symptoms (Menopause Rating Scale)]. Zentralblatt fur Gynakologie, 116(1), 16-23. Hay, A. G., Bancroft, J., & Johnstone, E. C. (1994). Affective symptoms in women attending a menopause clinic. The British journal of psychiatry, 164(4), 513-516. Hsu, C. C., Kuo, H. C., Chang, S. Y., Wu, T. C., Huang, K. E. (2011). The assessment of efficacy of Diascorea alata for menopausal symptom treatment in Taiwanese women. Climacteric. 14(1), 132-9. Huang, K. E., Xu, L., Nasri, N., & Jaisamrarn, U. (2010). The Asian Menopause Survey: knowledge, perceptions, hormone treatment and sexual function. Maturitas, 65(3), 276-283. Joffe, H., Petrillo, L., Viguera, A., Koukopoulos, A., Silver-Heilman, K., Farrell, A., Cohen, L. S. (2010). Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial. American journal of obstetrics and gynecology, 202(2), 171. e171-171. e111. Kaufert, P. A., Gilbert, P., & Tate, R. (1992). The Manitoba Project: a re-examination of the link between menopause and depression. Maturitas, 14(2), 143-155. Kessler, R. C., McGonagle, K. A., Swartz, M., Blazer, D. G., & Nelson, C. B. (1993). Sex and depression in the National Comorbidity Survey I: Lifetime prevalence, chronicity and recurrence. Journal of affective disorders, 29(2-3), 85-96. Lecrubier, Y., Sheehan, D. V., Weiller, E., Amorim, P., Bonora, I., Sheehan, K. H., Dunbar, G. C. (1997). The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. European Psychiatry, 12(5), 224-231. Lee, J.-K., Wu, C.-K., Lin, L.-Y., Cheng, C.-L., Lin, J.-W., Hwang, J.-J., & Chiang, F.-T. (2010). Insulin resistance in the middle-aged women with “Tigerish Back and Bearish Waist”. Diabetes research and clinical practice, 90(3), e85-e87. Llaneza, P., García-Portilla, M. P., Llaneza-Suárez, D., Armott, B., & Pérez-López, F. R. (2012). Depressive disorders and the menopause transition. Maturitas, 71(2), 120-130. Maartens, L., Knottnerus, J., & Pop, V. (2002). Menopausal transition and increased depressive symptomatology: a community based prospective study. Maturitas, 42(3), 195-200. Neugarten, B. L., & Kraines, R. J. (1965). ' Menopausal Symptoms' in Women of Various Ages. Obstetrical & Gynecological Survey, 20(6), 994-1001. NIH. (2005). National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Annals of Internal Medicine, 142(12), 1003. Potthoff, P., Heinemann, L., Schneider, H., Rosemeier, H., & Hauser, G. (2000). Menopause-Rating Skala (MRS): Methodische standardisierung in der deutschen bevölkerung. Zentralbl Gynakol, 122, 280-286. Rössler, W., Ajdacic‐Gross, V., Riecher‐Rössler, A., Angst, J., & Hengartner, M. P. (2016). Does menopausal transition really influence mental health? Findings from the prospective long‐term Zurich study. World Psychiatry, 15(2), 146-154. Ryan, J., Burger, H., Szoeke, C., Lehert, P., Ancelin, M.-L., & Dennerstein, L. (2009). A prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal women. Menopause (New York, NY), 16(3), 509. Ryan, J., Scali, J., Carrière, I., Peres, K., Rouaud, O., Scarabin, P.-Y., Ancelin, M.-L. (2011). Oestrogen receptor polymorphisms and late-life depression. The British journal of psychiatry, 199(2), 126-131. Schmidt, P. J., & Rubinow, D. R. (2009). Sex hormones and mood in the perimenopause. Annals of the New York Academy of Sciences, 1179(1), 70-85. Seritan, A. L., Iosif, A.-M., Park, J. H., DeatherageHand, D., Sweet, R. L., & Gold, E. B. (2010). Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center. Menopause, 17(2), 410-415. Sheehan, D., Lecrubier, Y., Sheehan, K. H., Janavs, J., Weiller, E., Keskiner, A., Dunbar, G. (1997). The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. European Psychiatry, 12(5), 232-241. Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., Dunbar, G. C. (1998). The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of clinical psychiatry. Sierra, B., Hidalgo, L. A., & Chedraui, P. A. (2005). Measuring climacteric symptoms in an Ecuadorian population with the Greene Climacteric Scale. Maturitas, 51(3), 236-245. Silva, M.-N. M. d., Brito, L. M. O., Chein, M. B. d. C., Brito, L. G. O., & Navarro, P. A. d. A. S. (2008). Depression in climacteric women: analysis of a sample receiving care at a university hospital in Maranhão, Brazil. Revista de Psiquiatria do Rio Grande do Sul, 30(2), 150-154. Soares, C. N., & Zitek, B. (2008). Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? Journal of psychiatry & neuroscience: JPN, 33(4), 331. Soules, M. R., Sherman, S., Parrott, E., Rebar, R., Santoro, N., Utian, W., & Woods, N. (2001). Executive summary: stages of reproductive aging workshop (STRAW). Climacteric, 4(4), 267-272. Stewart, D. E., Boydell, K., Derzko, C., & Marshall, V. (1992). Psychologic distress during the menopausal years in women attending a menopause clinic. The International Journal of Psychiatry in Medicine, 22(3), 213-220. Tangen, T., & Mykletun, A. (2008). Depression and anxiety through the climacteric period: an epidemiological study (HUNT-II). Journal of Psychosomatic Obstetrics & Gynecology, 29(2), 125-131. Taylor, J. V., Hickey, (2014). Menopause and depression: Is there a link? Maturitas, 79(2), 142-146. Travers, C., O'neill, S., King, R., Battistutta, D., & Khoo, S. (2005). Greene Climacteric Scale: norms in an Australian population in relation to age and menopausal status. Climacteric, 8(1), 56-62. Unsal, A., Tozun, M., & Ayranci, U. (2011). Prevalence of depression among postmenopausal women and related characteristics. Climacteric, 14(2), 244-251. Utian, W. H. (2001). Semantics, menopause-related terminology, and the STRAW reproductive aging staging system. Menopause, 8(6), 398-401. Vasconcelos-Raposo, J., Coelho, E., Fernandes, H. M., Rodrigues, C., Moreira, H., & Teixeira, C. (2012). Factor structure and normative data of the Greene Climacteric Scale among postmenopausal Portuguese women. Maturitas, 72(3), 256-262. Veras, A. B., Rassi, A., Valença, A. M., & Nardi, A. E. (2006). Prevalence of depressive and anxiety disorders in a Brazilian outpatient sample of menopausal women. Revista de Psiquiatria do Rio Grande do Sul, 28(2), 130-134. Wang, H.-L., Tai, M.-K., Hung, H.-M., & Chen, C.-H. (2013). Unique symptoms at midlife of women with osteoporosis and cardiovascular disease in Taiwan. Menopause, 20(3), 315-321. WHO. (1996). Research on the menopause in the 1990s: report of a WHO scientific group. WHO. (2004). International statistical classification of diseases and related health problems (Vol. 1): World Health Organization. Wojnar, M., Dróżdż, W., Araszkiewicz, A., Szymański, W., Nawacka-Pawlaczyk, D., Urbański, R., & Hegedus, A. (2003). Assessment and prevalence of depression in women 45–55 years of age visiting gynecological clinics in Poland. Archives of women’s mental health, 6(3), 193-201. Woods, N. F., Smith-DiJulio, K., Percival, D. B., Tao, E. Y., Mariella, A., & Mitchell, E. S. (2008). Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause, 15(2), 223-232. Woods, N. F., Smith-DiJulio, K., Percival, D. B., Tao, E. Y., Taylor, H. J., & Mitchell, E. S. (2007). Symptoms during the menopausal transition and early postmenopause and their relation to endocrine levels over time: observations from the Seattle Midlife Women's Health Study. Journal of Women's Health, 16(5), 667-677. Xu, Q., Anderson, D., & Courtney, M. (2010). A longitudinal study of the relationship between lifestyle and mental health among midlife and older women in Australia: findings from the Healthy Aging of Women Study. Health care for women international, 31(12), 1082-1096. Yang, Y., Chen, P., Wang, J., Lee, C., & Lai, J. (2009). Prescription pattern of traditional Chinese medicine for climacteric women in Taiwan. Climacteric, 12(6), 541-547. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/59780 | - |
dc.description.abstract | 更年期是不可避免的一個生命過程,已有許多研究證明停經過渡期和憂鬱症狀增加之間的關聯。由於更年期個體經歷差異很大,故更年期整合門診為時勢所趨,症狀評量表在更年期整合門診頗有助益,目前婦產科及精神科在臨床或研究更年期症狀時,常使用Greene更年期症狀量表來評估更年期症狀,只是在評估更年期症狀時常需併用憂鬱症狀量表以評量憂鬱症狀,若Greene更年期症狀量表之憂鬱分量表足以反映個案憂鬱嚴重度,即可用單一自填量表同時評量更年期症狀及憂鬱嚴重度,因此在臨床及研究上,特別是臨床,將更為方便。綜上所述,此研究的目的是希望能證明Greene更年期症狀量表之憂鬱分量表足以篩檢出憂鬱個案。
本研究以Greene更年期症狀量表及MINI國際神經精神醫學會談問卷為工具,針對北部某醫學中心之婦女身心醫學門診求診的個案進行評估調查,有效問卷共計215份,以SPSS 18.0進行資料分析。 研究結果發現經由醫師診斷患有憂鬱症之受試者在Greene更年期等各項症狀的情況皆明顯高於沒有憂鬱症之受試者。以達醫師診斷為憂鬱症為效標,探討Greene更年期症狀之憂鬱分量表在評估憂鬱症之最佳切點分數為5分,其ROC曲線下的面積 ± 標準誤為 0.883 ± 0.028,說明了在本研究樣本中,Greenee更年期症狀之憂鬱分量表中以5分做為篩選更年期婦女是否患有憂鬱症之評估標準最為適合。 根據本研究之結果認為可採用Greene更年期症狀之憂鬱分量表作為簡易篩檢更年期婦女憂鬱症狀的工具,並以5分作為最理想之切點分數。未來在臨床上甚或應用到社區,可考慮採用Greene更年期症狀量表之憂鬱分量表進行評估更年期婦女的憂鬱症狀,即可快速篩檢並視情況處理或轉介。 | zh_TW |
dc.description.abstract | Menopause is an inevitable life process. A number of studies proof that the positive association between depression and menopausal symptoms. Menopause integrated clinic is the trend of the times because the experience of menopause varies widely for each individual. Symptoms scales are helpful in the menopause integrated clinic. The Greene climacteric scale is often used as the tool to assess menopausal symptoms. However, the other depressive symptom scale needs to be used to measure depressive symptoms. If the depression subscale of Greene Climacteric Scale is sufficient to reflect the depression severity of the case, it can be used to measure menopausal symptoms and depression severity at the same time. Therefore, it will be more convenient in clinical and research, especially in clinical. The purpose of this study is to assess the feasibility of using depression scores of Greene climacteric scale to screen depression.
The participants were 215 patients who visited the menopause-related mood clinic in a medical center in north Taiwan. The study use the Greene climacteric scale and the Mini-International Neuropsychiatric Interview as the tool, and the SPSS 18.0 for analysis. The results indicate that the subjects diagnosed with depression by psychiatrists were significantly higher in all subscales of the Greene Climacteric Scale than those without depression. Using the Mini-International Neuropsychiatric Interview as the standard of comparison, the ROC analysis suggests that the depression subscale of Greene Climacteric Scale score of 5 or more can be used as an optimal cutoff point for identifying depression. AUC ± standard error (SE) = 0.829 ± 0.036. The results demonstrate that the depression subscale of Greene Climacteric Scale is a reliable and valid instrument for evaluating depression among menopause women, and 5 and above are optimal cutoff scores. The depression subscale of Greene Climacteric Scale can be used to quickly screen for menopausal women with depressive symptoms in clinical or even applied to the community. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T09:37:36Z (GMT). No. of bitstreams: 1 ntu-106-R00847044-1.pdf: 1419116 bytes, checksum: 2824acd1d6ab5cc7dcbfb531c5527754 (MD5) Previous issue date: 2017 | en |
dc.description.tableofcontents | 第一章 導論 1
第一節 實習單位特色與簡介 1 第二節 研究動機與目的 3 第二章 文獻探討 5 第一節 更年期概述 5 第二節 更年期與憂鬱症的機轉及流行病學研究 11 第三節 更年期測量量表的選擇與討論 17 第四節 憂鬱症評量工具的選擇與討論 21 第三章 研究方法 24 第一節 研究架構 24 第二節 研究設計 24 第四章 研究結果 27 第一節 受試者人口學資料及描述性統計 27 第二節 不同人口學變項與Greene更年期症狀之相關與差異性 29 第三節 Greene更年期症狀量表之切點分數 35 第四節 Greene量表篩檢出憂鬱個案之分析 38 第五章 討論與建議 45 第一節 討論 45 第二節 建議 49 第三節 研究限制 50 參考文獻 52 中文文獻 52 英文文獻 54 附錄一 Greene更年期症狀量表 64 附錄二 MINI量表 65 附錄三 人體試驗委員會「同意臨床試驗證明書」 73 附錄四 受試者同意書 74 | |
dc.language.iso | zh-TW | |
dc.title | 證驗Greene更年期症狀量表之憂鬱分量表篩檢憂鬱症的適用性:以北部某醫學中心為例 | zh_TW |
dc.title | Feasibility of Using Depression Scores of Greene Climacteric Scale to Screen Depression: The case of A Medical Center in Taoyuan City | en |
dc.type | Thesis | |
dc.date.schoolyear | 105-1 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 劉嘉逸 | |
dc.contributor.oralexamcommittee | 楊銘欽 | |
dc.subject.keyword | 更年期,憂鬱,Greene更年期量表,MINI國際神經精神醫學會談問卷, | zh_TW |
dc.subject.keyword | Menopause,Depression,Greene Climacteric Scale,Mini-International Neuropsychiatric Interview, | en |
dc.relation.page | 76 | |
dc.identifier.doi | 10.6342/NTU201700495 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2017-02-10 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 公共衛生碩士學位學程 | zh_TW |
顯示於系所單位: | 公共衛生碩士學位學程 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-106-1.pdf 目前未授權公開取用 | 1.39 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。